Ramón Pérez-Álvarez Selected Research

Therapeutics

1/2015	Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis.
6/2012	A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramón Pérez-Álvarez Research Topics

Disease

2	Infections 01/2015 - 01/2014
1	Fibrosis (Cirrhosis) 01/2015
1	Hepatitis C 01/2015
1	Chronic Hepatitis C 06/2012

Drug/Important Bio-Agent (IBA)

1	BilirubinIBA 01/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015
1	AlbuminsIBA 01/2015
1	KIR ReceptorsIBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2015 - 06/2012